ÂÜÀòÂÒÂ×

Mike Grey is an experienced executive in the life sciences sector, currently serving as Chairman of Sorriso Pharmaceuticals, Mirum Pharmaceuticals, and Executive Chairman at Plexium, Spruce Biosciences, and Reneo Pharmaceuticals. With a long-standing involvement in venture capital as a Venture Partner at Pappas Ventures since 2010, Mike has contributed to the development of over 50 life sciences companies. Previous roles include Executive Chairman at Amplyx Pharmaceuticals, Executive Chairman of ZIARCO GROUP LIMITED, and President & CEO of Lumena Pharmaceuticals, which was acquired by Shire for $260 million. Mike's leadership and expertise have significantly impacted several biotechnology and biopharmaceutical ventures throughout a distinguished career.